UniQure presses go on Huntington’s gene therapy trial

UniQure presses go on Huntington’s gene therapy trial

Source: 
Pharmaforum
snippet: 

UniQure has started screening patients for its phase 1/2 trial of gene therapy AMT-130 for Huntington’s disease, and says it hopes to start treating the first subject in late 2019 or early 2020.